KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Common Equity (2016 - 2025)

Historic Common Equity for Cme (CME) over the last 17 years, with Q3 2025 value amounting to $28.2 billion.

  • Cme's Common Equity fell 9.18% to $28.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $28.2 billion, marking a year-over-year decrease of 9.18%. This contributed to the annual value of $26.5 billion for FY2024, which is 93.87% down from last year.
  • According to the latest figures from Q3 2025, Cme's Common Equity is $28.2 billion, which was down 9.18% from $27.7 billion recorded in Q2 2025.
  • Cme's Common Equity's 5-year high stood at $28.3 billion during Q3 2022, with a 5-year trough of $26.5 billion in Q4 2024.
  • Moreover, its 5-year median value for Common Equity was $27.4 billion (2021), whereas its average is $27.4 billion.
  • Within the past 5 years, the most significant YoY rise in Cme's Common Equity was 453.31% (2022), while the steepest drop was 190.0% (2022).
  • Cme's Common Equity (Quarter) stood at $27.4 billion in 2021, then decreased by 1.9% to $26.9 billion in 2022, then fell by 0.52% to $26.7 billion in 2023, then decreased by 0.94% to $26.5 billion in 2024, then increased by 6.43% to $28.2 billion in 2025.
  • Its last three reported values are $28.2 billion in Q3 2025, $27.7 billion for Q2 2025, and $27.0 billion during Q1 2025.